The challenge of choosing in cardiovascular risk management

Autor: Hoogeveen, R.M., Hanssen, N.M.J., Brouwer, J.R., Mosterd, A., Tack, C.J., Kroon, A.A., Borst, G.J. de, Berg, J. ten, Trier, T. van, Lennep, J.R. van, Liem, A., Serne, E., Visseren, F.L.J., Cornel, J.H., Peters, R.J.G., Jukema, J.W., Stroes, E.S.G., PANORAMA Working Grp

Publikováno v: Netherlands Heart Journal
Netherlands Heart Journal, 30, 47-57
Netherlands Heart Journal, 30, 1, pp. 47-57
Netherlands Heart Journal, 30, 47-57. BOHN STAFLEU VAN LOGHUM BV
Hoogeveen, R M, Hanssen, N M J, Brouwer, J R, Mosterd, A, Tack, C J, Kroon, A A, de Borst, G J, ten Berg, J, van Trier, T, van Lennep, J R, Liem, A, Serne, E, Visseren, F L J, Cornel, J H, Peters, R J G, Jukema, J W & Stroes, E S G 2022, ' The challenge of choosing in cardiovascular risk management ', Netherlands Heart Journal, vol. 30, no. 1, pp. 47-57 . https://doi.org/10.1007/s12471-021-01599-y

Contains fulltext : 248734.pdf (Publisher’s version ) (Open Access) Cardiovascular disease (CVD) is a major cause of morbidity and mortality worldwide. For many years guidelines have listed optimal preventive therapy. More recently, novel therapeut

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::775cb416a80da6581e2e4ced2e84c4dd
https://doi.org/10.1007/s12471-021-01599-y

[Anti-inflammatory therapy in cardiovascular disease; from hypothesis to future guideline?]

Autor: Hoogeveen, R.M., Stroes, E.S., Cornel, J.H.

Publikováno v: Nederlands Tijdschrift voor Geneeskunde, 164

Item does not contain fulltext Atherosclerosis is a lipid-driven inflammatory disease, in which both lipids and inflammation can be considered treatment targets. The CANTOS-trial, using the IL-1β monoclonal antibody canakinumab, has proven the conce

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::951127efa2985f945baf4b1b86c11b67
https://hdl.handle.net/2066/229077

Elevated lipoprotein(a) levels increase risk of secondary major adverse cardiovascular events in patients undergoing carotid endarterectomy

Autor: Waissi, F., Timmerman, N., Dekker, M., Hoogeveen, R.M., Schnitzler, J.G., De Borst, G.J., Stroes, E., De Kleijn, D.P.V., Kroon, J.

Publikováno v: In Atherosclerosis December 2020 315:e146-e146

Atherogenic lipoprotein(A) increases vascular glycolysis, thereby facilitating inflammation and leukocyte extravasation

Autor: Schnitzler, J.G., Hoogeveen, R.M., Ali, L., Prange, K., Weeghel, M.V., Versloot, M., Waissi, F., Houtkooper, R., De Kleijn, D.P.V., De Winther, M., Koschinsky, M., Tsimikas, S., Witztum, J.L., Stroes, E., Kroon, J.

Publikováno v: In Atherosclerosis December 2020 315:e10-e11

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.